NCT03964168View on ClinicalTrials.gov

An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

July 31, 2019

Primary Completion Date

March 3, 2020

Study Completion Date

March 3, 2020

Conditions
Psoriasis
Interventions
DRUG

Biologic Agent

Patients who discontinued a bioloic agent

Trial Locations (1)

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

All Listed Sponsors
collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

Psoriasis Treatment Center of Central New Jersey

OTHER

NCT03964168 - An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers | Biotech Hunter | Biotech Hunter